These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 6998282)

  • 1. Acute iron poisoning. A review.
    Robotham JL; Lietman PS
    Am J Dis Child; 1980 Sep; 134(9):875-9. PubMed ID: 6998282
    [No Abstract]   [Full Text] [Related]  

  • 2. Benefits of parenteral deferoxamine for acute iron poisoning.
    Tenenbein M
    J Toxicol Clin Toxicol; 1996; 34(5):485-9. PubMed ID: 8800185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antidotes in acute iron poisoning. Animal experimental studies].
    Pfister G; Catsch A; Nigrović V
    Arzneimittelforschung; 1967 Jun; 17(6):748-51. PubMed ID: 5632378
    [No Abstract]   [Full Text] [Related]  

  • 4. Chelation therapy in acute iron poisoning.
    Leikin S; Vossough P; Mochir-Fatemi F
    J Pediatr; 1967 Sep; 71(3):425-30. PubMed ID: 6034795
    [No Abstract]   [Full Text] [Related]  

  • 5. Deferoxamine treatment for acute iron intoxication in pregnancy.
    Khoury S; Odeh M; Oettinger M
    Acta Obstet Gynecol Scand; 1995 Oct; 74(9):756-7. PubMed ID: 7572116
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of exchange transfusion and deferoxamine in the treatment of acute iron poisoning.
    Movassaghi N; Purugganan GG; Leikin S
    J Pediatr; 1969 Oct; 75(4):604-8. PubMed ID: 5809838
    [No Abstract]   [Full Text] [Related]  

  • 7. Of iron and ancient mariners.
    Banner W
    Ann Emerg Med; 1997 Nov; 30(5):687-8. PubMed ID: 9360583
    [No Abstract]   [Full Text] [Related]  

  • 8. Studies in acute iron poisoning. I. Desferrioxamine In the treatment of acute iron poisoning: clinical observations, experimental studies, and theoretical considerations, by Charles F. Whitten et al, Pediatrics, 1965;36:322-335; and Studies in acute iron poisoning. II. Further observations on desferrioxamine in the treatment of acute experimental iron poisoning, by Charles F. Whitten et al, Pediatrics, 1966;38:102-110.
    Cohen CS
    Pediatrics; 1998 Jul; 102(1 Pt 2):241-3. PubMed ID: 9651443
    [No Abstract]   [Full Text] [Related]  

  • 9. Risks of parenteral deferoxamine for acute iron poisoning.
    Howland MA
    J Toxicol Clin Toxicol; 1996; 34(5):491-7. PubMed ID: 8800186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Iron ingestions--the Children's Mercy Hospital.
    Green VA
    Clin Toxicol; 1971 Jun; 4(2):245-52. PubMed ID: 5125346
    [No Abstract]   [Full Text] [Related]  

  • 11. Deferoxamine as a chelating agent.
    McEnery JT
    J Pediatr; 1968 Jan; 72(1):147-8. PubMed ID: 5634936
    [No Abstract]   [Full Text] [Related]  

  • 12. Management of the drug overdose patient. Part II. Specific antidotes.
    Bianchine JR; Couri D
    Ohio State Med J; 1977 Jul; 73(7):451-2. PubMed ID: 882237
    [No Abstract]   [Full Text] [Related]  

  • 13. [Deferoxamine].
    Jonker-Wuite PG
    Pharm Weekbl; 1969 Aug; 104(35):1069-75. PubMed ID: 5806268
    [No Abstract]   [Full Text] [Related]  

  • 14. Radiology in the management of acute iron poisoning.
    Hosking CS
    Med J Aust; 1969 Mar; 1(11):576-9. PubMed ID: 5782096
    [No Abstract]   [Full Text] [Related]  

  • 15. Accidental iron poisoning in childhood. Six cases including one fatality.
    Greenblatt DJ; Allen MD; Kock-Weser J
    Clin Pediatr (Phila); 1976 Sep; 15(9):835-8. PubMed ID: 954339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Iron intoxication in two adult patients.
    Eriksson F; Johansson SV; Mellstedt H; Stranberg O; Wester PO
    Acta Med Scand; 1974 Sep; 196(3):231-6. PubMed ID: 4417152
    [No Abstract]   [Full Text] [Related]  

  • 17. Iron complexation with oral deferoxamine in a swine model.
    Dean BS; Oehme FW; Krenzelok EP; Griffith GR; Hines RH
    Vet Hum Toxicol; 1996 Apr; 38(2):96-8. PubMed ID: 8693694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute iron poisoning: assessment of severity and prognosis.
    James JA
    J Pediatr; 1970 Jul; 77(1):117-9. PubMed ID: 5450272
    [No Abstract]   [Full Text] [Related]  

  • 19. An objective criterion for the cessation of deferoxamine therapy in the acutely iron poisoned patient.
    Yatscoff RW; Wayne EA; Tenenbein M
    J Toxicol Clin Toxicol; 1991; 29(1):1-10. PubMed ID: 2005657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deferoxamine mesylate (Desferal mesylate). A specific iron-chelating agent for treating acute iron intoxication.
    Clin Pharmacol Ther; 1969; 10(4):595-6. PubMed ID: 5815783
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.